News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Talazoparib in Combination With Enzalutamide for Prostate Cancer – FDA Oncology
Photo from FDA Oncology/X
Mar 15, 2024, 18:07

Talazoparib in Combination With Enzalutamide for Prostate Cancer – FDA Oncology

FDA Oncology posted on X/Twitter:

“FDA Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer – Journal of Clinical Oncology. 1st author Brian Heiss, last author Daniel Suzman.“

Image

View additional information.
Source: FDA Oncology/X

Brian Heiss cancer Daniel Suzman Enzalutamide FDA Approval Summary FDA Oncology Journal of Clinical Oncology OncoDaily Oncology Talazoparib
Special Coverage
Insight
Dec 23, 2024, 21:21
Anil D’Cruz: A great initial step in improving access to healthcare for all
Insight
Dec 23, 2024, 21:19
Ahmed Kotb: CML Treatment Algorithm guided by NCCN and ELN
Insight
Dec 23, 2024, 21:16
Hung Trinh: CAR-T cell therapy for the treatment of adult high-grade gliomas
Insight
Dec 23, 2024, 21:14
Mainak Bardhan: Zero-shot patient-to-trial matching with large language models
Insight
Dec 23, 2024, 21:09
Supriya Peshin: Unpacking Trastuzumab-Induced Cardiomyopathy
Insight
Dec 23, 2024, 20:37
Guilherme Nader Marta: Two perspectives on anthracycline use in breast cancer
Blog
Dec 23, 2024, 20:33
Enrique Grande: When this time of year comes around we all look back and evaluate ourselves
Science
Dec 23, 2024, 20:29
Alba Fiorentino: An oligometastatic lung cancer case report with a durable complete metabolic response
Blog
Dec 23, 2024, 20:18
Vun-Sin Lim: Recap of the ISMTE Asia-Pacific Advisory Council office hour events
Blog
Dec 23, 2024, 20:14
Webinar on how to get the most out of your MASCC membership
Blog
Dec 23, 2024, 20:13
Pamela was diagnosed with stage III colon cancer at the age of 49 - Colorectal Cancer Alliance
Career
Dec 23, 2024, 20:11
MinhTri Nguyen: Thrilled to be selected for the Stanford Physician Leadership Certificate Program